Skip to main content

Tyra Biosciences, Inc.

TYRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001863127

In the last 90 days, Tyra Biosciences, Inc. insiders filed 1 open-market purchase and 0 sales; 168 institutions reported holding it in 13F filings for Q2 2026, worth $2.22B in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Tyra Biosciences, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of TYRA: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders117121+4
Shares53.6M56.6M+3.02M (+5.6%)
Value$499.5M$541.5M+$42.0M (+8.4%)

New holders (18)

Institutions that held Tyra Biosciences, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to TYRA in Q2 2025
InstitutionSharesValue% of portfolio
Ameriprise Financial Inc80,602$771.4K0.00%
Susquehanna Portfolio Strategies, LLC48,644$465.5K0.01%
Trexquant Investment LP44,681$427.6K0.00%
PDT Partners, LLC43,310$414.5K0.02%
XTX Topco Ltd34,601$331.1K0.01%
Dynamic Technology Lab Private Ltd34,115$326.0K0.04%
Squarepoint Ops LLC31,408$300.6K0.00%
Alps Advisors Inc28,729$274.9K0.00%
AQR Capital Management LLC28,712$274.8K0.00%
Corton Capital Inc.24,346$233.0K0.27%
Public Employees Retirement System of Ohio18,512$177.2K0.00%
Price T Rowe Associates Inc12,022$116.0K0.00%
Versant Capital Management, Inc819$7.84K0.00%
GAMMA Investing LLC215$2.06K0.00%
True Wealth Design, LLC142$1.36K0.00%
Clearstead Advisors, LLC125$1.20K0.00%
Signaturefd, LLC43$4120.00%
Larson Financial Group LLC36$3450.00%

Sold out (14)

Institutions that held Tyra Biosciences, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.